Advances in the study of S100A9 in cardiovascular diseases

首页 > 成果 > 详情

认领

导出

Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Chen, Fengling;He, Ziyu;Wang, Chengming;Si, Jiajia;Chen, Zhu*;...

通讯作者：

Chen, Zhu;Guo, Y

作者机构：

[Guo, Yuan; Chen, Fengling; Chen, Zhu] Univ South China, Hengyang Med Sch, Hengyang, Hunan, Peoples R China.

[He, Ziyu; Guo, Yuan; Chen, Fengling; Wang, Chengming] Cent South Univ, Zhuzhou Hosp, Xiangya Sch Med, Dept Cardiovasc Med, Zhuzhou, Hunan, Peoples R China.

[Si, Jiajia; Guo, Yuan; Chen, Zhu] Hunan Univ Technol, Hunan Key Lab Biomed Nanomat & Devices, Zhuzhou, Peoples R China.

[Chen, Zhu; Guo, Yuan; Guo, Y] Univ South China, Hengyang Med Sch, 28 West Changsheng Rd, Hengyang 421001, Hunan, Peoples R China.

通讯机构：

[Chen, Z; Guo, Y ] U

Univ South China, Hengyang Med Sch, 28 West Changsheng Rd, Hengyang 421001, Hunan, Peoples R China.

语种：

英文

期刊：

Cell Proliferation

ISSN：

0960-7722

年：

2024

页码：

e13636

DOI：

10.1111/cpr.13636

基金类别：

Health Research Project of Hunan Provincial Health Commission

机构署名：

本校为第一且通讯机构

摘要：

S100A9 is released by immune and tissue cells in response to stressors such as damage, inflammation, and oxidative stress. This leads to the amplification of inflammation, anti‐inflammatory effects, induction of endothelial dysfunction, promotion of vascular microcalcification, as well as stimulation of cell proliferation, autophagy, apoptosis, and death. S100A9 can serve as a biomarker for diagnosis, prediction, and evaluation of cardiovascular diseases, and it is also considered a potential therapeutic target. Abstract Cardiovascular disease...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

Advances in the study of S100A9 in cardiovascular diseases

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问